查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726402

全球預測疾病分析市場：市場規模、佔有率、趨勢分析（按組件、部署方法、最終用途和地區）、細分市場預測（2025-2030 年）

Predictive Disease Analytics Market Size, Share & Trends Analysis Report By Component (Hardware, Software & Services), By Deployment (On-premise, Cloud-based), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

預測疾病分析市場的成長與趨勢：

根據 Grand View Research, Inc. 的新報告，全球預測疾病分析市場規模預計到 2030 年將達到 102 億美元，2025 年至 2030 年的複合年成長率為 22.7%。

預測疾病分析是指醫療保健組織、醫院和醫生用來分析和處理患者數據以提供數據主導的優質護理、準確診斷和個人化治療的軟體解決方案。預測分析是一種改善醫療保健患者治療結果的先進技術。

此外，醫療保健提供者使用預測分析解決方案來了解疾病傳播、疾病管理、風險管理和軌跡，並為患者提供適當的護理以獲得最佳結果。醫療保健提供者使用它來評估個人健康的風險率以及預測和準備未來的結果。各個層面的使用以避免不必要的開支也增加了這項技術的使用，預計這種使用將在整個預測期內持續下去。因此，全球預測疾病分析市場預計將成長。

預測分析在應對 COVID-19 挑戰、減少不良患者治療結果的發生率以及解決危機期間的資源管理方面發揮關鍵作用。疫情期間產生的大量患者數據不僅為分析公司和醫療保健部門提供了正確分析疾病傳播的數據，還有助於資源配置。包括醫院在內的多家發展機構正在使用預測分析來確定患者出現嚴重症狀、感染疾病/疾病軌跡和其他幾個參數的機率。例如，2020 年，美國克利夫蘭診所的研究人員創建了一個自動分析模型來預測個人檢測呈陽性的可能性。因此，它正在推動市場成長。

由於慢性病負擔不斷加重、個人化和實證醫學的出現、醫療保健領域對效率的需求不斷成長，以及透過消除不必要成本來降低醫療保健支出的需求不斷成長，全球市場正在迅速擴張。根據疾病管制中心的數據，每 10 個美國人中就有 6 個患有至少一種慢性疾病，例如心臟病、中風、癌症或糖尿病。因此，產品需求的增加進一步促進了市場成長。

推動市場成長的另一個重要原因是使用實證醫學為正確的患者提供正確的治療。近年來，電子健康記錄(EHR) 在病患記錄中的使用增加，在美國，執業醫師對 EHR 的採用率從 2008 年的 42% 增加到 2021 年的近 88%。預測性醫療分析利用 EHR 推薦最佳治療方案和藥物。這不僅顯著降低了患者的醫療費用，而且還改善了治療效果。電子醫療系統、分析工具和人工智慧（AI）的採用有望推動市場發展。由於全球慢性病負擔不斷加重，醫療費用逐年上漲。

預測疾病分析市場中的公司正在不斷擴大其產品和服務組合併加速其發展。例如，2022 年 6 月，健康顧問公司 Engagys LLC 宣布推出一項針對醫療系統、健康計畫和醫療技術領導者的全新經濟實惠的訂閱服務。我們的執行諮詢服務旨在為醫療保健客戶參與負責人提供實用、可操作的指導、見解和最佳實踐。預計這將加強公司在預測分析解決方案中的地位並進一步促進市場成長。

預測疾病分析市場：分析概述

  • 預計預測期內雲端基礎的解決方案將以最高的複合年成長率成長。易於儲存、廉價的資本要求、更高的靈活性和效率是其發展的驅動力。
  • 根據最終用途，醫療保健支付方部門在 2023 年佔據了市場主導地位。保險公司、健康計畫發起人和其他第三方支付方等支付方是醫療保健環境中預測分析的主要受益者之一。從而促進該領域的成長。
  • 在北美，由於慢性病盛行率上升、預防保健意識增強以及老年人口比例增加，預計該地區將佔據最大的市場佔有率。

目錄

第1章 分析方法與範圍

第2章執行摘要

3. 預測疾病分析市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 預測疾病分析市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • 法律規範
    • 新興科技趨勢
    • 案例研究和見解
    • COVID-19影響分析

第4章預測疾病分析市場：各組成部分的估計和趨勢分析

  • 細分儀表板
  • 全球預測疾病分析各組成部分的變異分析
  • 全球預測疾病分析市場規模及趨勢分析（2018-2030）
  • 軟體和服務市場
  • 五金市場

第5章預測疾病分析市場：按部署方法的估計和趨勢分析

  • 細分儀表板
  • 全球預測疾病分析市場趨勢分析（按部署法）
  • 全球預測疾病分析市場規模和趨勢分析（按部署類型）（2018-2030 年）
  • 本地市場
  • 雲端基礎的市場

6. 預測疾病分析市場：依最終用途的估計和趨勢分析

  • 細分儀表板
  • 全球預測疾病分析變異分析（依最終用途）
  • 全球預測疾病分析市場規模和趨勢分析（按最終用途）（2018-2030 年）
  • 醫療保健付款人
  • 醫療保健提供者
  • 其他最終用戶

第7章預測疾病分析市場：按地區估計和趨勢分析

  • 各地區市場佔有率分析（2024 年及 2030 年）
  • 市場儀表板：按地區
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 公司/競爭對手分類
  • 企業市場分析（2024年）
  • 公司簡介/上市公司
    • Oracle
    • Cerner Corporation
    • IBM
    • SAS
    • Allscripts Healthcare Solutions Inc.
    • MedeAnalytics, Inc.
    • Health Catalyst
    • Apixio Inc
    • GE Healthcare（a division of General Electric Company）
    • Siemens Healthineers
Product Code: GVR-4-68040-043-8

Predictive Disease Analytics Market Growth & Trends:

The global predictive disease analytics market size is expected to reach USD 10.2 billion by 2030 and is expected to expand at 22.7% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. Predictive disease analytics refers to software solutions used by healthcare organizations, hospitals, and physicians to analyze and process patient data in order to provide data-driven, high-quality care, precise diagnostics, and individualized treatments. Predictive analytics is an advanced method to enhance patient outcomes in healthcare.

Additionally, predictive analytics solutions are used by healthcare providers to comprehend disease prevalence, disease management, risk management & trajectories, and to provide suitable medical care to patients for optimal outcomes. Healthcare providers use it to evaluate the risk rate to an individual's health as well as predict future outcomes in preparation. Its use at various levels to avoid unnecessary expenditure had also increased the utilization of this technology, which is anticipated to continue throughout the forecast period. As a result, the global predictive disease analytics market is expected to grow.

Predictive analytics has played a significant part in combating COVID-19 problems, decreasing the incidence of poor outcomes for patients, and addressing resource management during the crisis. The massive amount of patient data produced during the outbreak not only provided analytics firms and the healthcare sector with data to properly analyze disease spread, but it also aided in resource allocation. Several institutions, including hospitals, was using predictive analytics to determine the probability of a patient developing severe symptoms, the trajectory of their infection/disease, and several other parameters. For instance, in 2020, researchers at the Cleveland Clinic in the U. S. created an automated analytics model that predicted an individual's chance of testing positive. Hence, propelling the market growth.

The global market is expanding rapidly as a result of the increasing burden of chronic diseases, the emergence of personalized and evidence-based medicine, the growing need for increased efficiency in the healthcare sector, and the growing demand to reduce healthcare costs by eliminating unnecessary costs. As per the center for disease control, six out of every ten Americans have at least one chronic illness, such as heart disease or stroke, cancer, or diabetes. Hence, it will increase the product demand and further boost the market growth.

Another important reason driving market growth is the use of evidence-based medicine to provide the right kind of treatment to the right patient. The utilization of Electronic Health Records (EHRs) for patient records has increased in recent years, with adoption of EHRs in the case of office-based doctors increasing from 42% in 2008 to nearly 88% in 2021 in the U. S. Healthcare predictive analytics makes use of EHRs to recommend the best course of action in the event of a medical treatment or medication. This not only greatly reduces patient costs but also leads to improved outcomes. The adoption of electronic health systems, analytics tools, and artificial intelligence (AI) are expected to drive market development. The expense of healthcare has risen over the years owing to the increasing burden of chronic diseases on a global level.

The companies in the predictive disease analytics market are continuously expanding their product and services portfolio to accelerate the development of the product. For instance, in June 2022, Engagys LLC, a Health Consultant Company, announced the debut of a new affordable subscription service for healthcare systems, health plans, & healthcare technology leaders. Executive Advisory Services is intended to provide healthcare customer engagement practitioners with practical and actionable guidance, insights, and best practices that they can put to use immediately. This is expected to strengthen the company's position in predictive analytics solution and further boost the market growth.

Predictive Disease Analytics Market Report Highlights:

  • Cloud-based solutions are anticipated to have the highest CAGR during the forecast period. The ease of storage, inexpensive capital requirements, increased flexibility, and efficiency are attributed to its development.
  • On the basis of end user, payer segment dominated the market in 2023.Payers, such as insurance firms, health plan sponsors, as well as other third-party payers, are among the primary beneficiaries of predictive analytics in healthcare settings. Thus, boosting the segment growth.
  • Due to the rising prevalence of chronic diseases, greater awareness of preventive health and rising percentage of geriatric population in North America, the region had the largest market share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Component Type Segment
    • 1.2.2. Deployment Segment
    • 1.2.3. End User Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Predictive Disease Analytics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in government initiatives and an increasing amount of money being invested in the healthcare industry
      • 3.2.1.2. Technological advancements in AI and machine learning
      • 3.2.1.3. Increasing prevalence of chronic diseases
      • 3.2.1.4. Growing shift towards personalized medicine
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Growing data privacy concerns
      • 3.2.2.2. Lack of skilled professionals
      • 3.2.2.3. High implementation cost
  • 3.3. Predictive disease analytics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
    • 3.3.3. Regulatory Framework
    • 3.3.4. Emerging Technologies Trends
    • 3.3.5. Case Study & Insights
      • 3.3.5.1. Use Cases
    • 3.3.6. COVID-19 Impact Analysis

Chapter 4. Predictive Disease Analytics Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Predictive Disease Analytics Movement Analysis
  • 4.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by Component, 2018 - 2030 (USD Million)
  • 4.4. Software and Services Market
    • 4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Hardware Market
    • 4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Predictive Disease Analytics Market: Deployment Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Predictive Disease Analytics Movement Analysis
  • 5.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by Component, 2018 - 2030 (USD Million)
  • 5.4. On-premise Market
    • 5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Cloud-based Market
    • 5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Predictive Disease Analytics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Predictive Disease Analytics Market End Use Movement Analysis
  • 6.3. Global Predictive Disease Analytics Market Size & Trend Analysis, by End Use, 2018 - 2030 (USD Million)
  • 6.4. Healthcare Payers
    • 6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Other End Users
    • 6.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Predictive Disease Analytics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 - 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Profiles/Listing
    • 8.3.1. Oracle
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Cerner Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. IBM
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. SAS
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Allscripts Healthcare Solutions Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MedeAnalytics, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Health Catalyst
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Apixio Inc
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. GE Healthcare (a division of General Electric Company)
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Siemens Healthineers
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Predictive disease analytics market, by component, 2018 - 2030 (USD Million)
  • Table 4 North America Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 5 North America Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 9 Canada Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 10 Canada Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 12 Mexico Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 13 Mexico Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 14 Mexico Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 17 Europe Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 18 Europe Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 20 UK Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 21 UK Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Germany Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 23 Germany Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 24 Germany Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 26 France Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 27 France Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 29 Italy Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 30 Italy Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 32 Spain Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 33 Spain Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 35 Denmark Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 36 Denmark Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 38 Sweden Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 39 Sweden Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 41 Norway Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 42 Norway Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 48 China Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 49 China Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 51 Japan Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 52 Japan Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 54 India Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 55 India Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 58 South Korea Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 60 Australia Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 61 Australia Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 63 Thailand Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 64 Thailand Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 66 Latin America Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 67 Latin America Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 68 Latin America Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 71 Brazil Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 74 Argentina Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 75 MEA Predictive disease analytics market, by country, 2018 - 2030 (USD Million)
  • Table 76 MEA Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 77 MEA Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 78 MEA Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 81 South Africa Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 86 UAE Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 87 UAE Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Predictive disease analytics market, by application type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Predictive disease analytics market, by deployment, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Predictive disease analytics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Predictive disease analytics market: Market outlook
  • Fig. 5 Predictive disease analytics market: Segment outlook
  • Fig. 6 Predictive disease analytics market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Predictive disease analytics market driver impact
  • Fig. 9 Predictive disease analytics market restraint impact
  • Fig. 10 Predictive disease analytics market: Component outlook and key takeaways
  • Fig. 11 Predictive disease analytics market: Component movement analysis
  • Fig. 12 Software & Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Hardware market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Predictive disease analytics market: Deployment Mode outlook and key takeaways
  • Fig. 15 Predictive disease analytics market: Deployment Mode movement analysis
  • Fig. 16 On-premise market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 17 Cloud-based market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 18 Predictive disease analytics market: End User outlook and key takeaways
  • Fig. 19 Predictive disease analytics market: End User movement analysis
  • Fig. 20 Healthcare Payers Market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Healthcare Providers Market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 22 Other End Users market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Global Predictive disease analytics market: Regional outlook and key takeaways
  • Fig. 24 Global Predictive disease analytics market: Regional movement analysis
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Key country dynamics
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)